Head & Neck Cancers | Specialty

The OncLive Head and Neck Cancer condition center page is a comprehensive resource for clinical news and expert insights on treatment for patients with head and neck cancer. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research within head and neck cancer.

Dr. Mell on Risk Stratification for Head and Neck Cancer

November 8th 2017

Loren K. Mell, MD, assistant professor, Department of Radiation Medicine and Applied Sciences, University of California, San Diego School of Medicine, discusses risk stratification for patients with head and neck cancer.

Dr. Cohen on the Quality of Life in Head and Neck Cancer

November 7th 2017

Ezra Cohen, MD, associate director, Moores Cancer Center at the University of California, San Diego, discusses the unmet need facing the quality of life for patients with head and neck cancer.

Dr. Bouvet on Remaining Challenges With Thyroid Cancer Surgery

November 3rd 2017

Michael Bouvet, MD, professor of surgery, University of California, San Diego, discusses the remaining challenges with thyroid cancer surgery.

Dr. Sacco on Upfront Treatments for Head and Neck Cancer

November 3rd 2017

Assuntina G. Sacco, MD, assistant professor of medicine, medical oncologist, UC San Diego Health, discusses upfront treatment for patients with head and neck cancer.

Dr. Califano on the Future of Surgery in Head and Neck Cancer

November 3rd 2017

Joseph A. Califano, MD, professor of surgery, University of California, San Diego, discusses the future of surgery in head and neck cancer.

Expert Differentiates Carcinogen-Induced and Virally Associated HNSCC

October 30th 2017

Kathryn A. Gold, MD, discusses HPV status and prognosis, as well recognizing risk factors of virally-associated head and neck squamous cell carcinoma.

Immunotherapy, New Targeted Approaches Explored in Thyroid Cancer

October 30th 2017

Gregory Daniels, MD, PhD, discusses the current treatment landscape of thyroid cancer and the development of immunotherapy for patients with this disease.

Dr. Daniels Discusses Treatment Options in Thyroid Cancer

October 27th 2017

Gregory A. Daniels, MD, PhD, medical oncologist, associate professor of medicine, UC San Diego Health, discusses treatment options for patients with thyroid cancer.

Dr. Cohen Discusses Entrectinib in Head and Neck Cancer

October 26th 2017

Ezra Cohen, MD, associate director, Moores Cancer Center at the University of California, San Diego, discusses the role of entrectinib in treating patients with head and neck cancer.

Role of Immunotherapy Expanding in Head and Neck Cancer

October 25th 2017

Ezra Cohen, MD, discusses the role of immunotherapy, the potential of entrectinib, and the importance of multidisciplinary teams for the treatment of patients with head and neck cancer.

Durvalumab Has Emerging Role in Head and Neck Cancer

October 24th 2017

Daniel Zandberg, MD, discusses results from the HAWK study as well as current combination approaches for patients with head and neck cancer.

Photodynamic Therapy: Looking at Treatment of Early-Stage Oral Cancer in a New Light

October 24th 2017

Although surgery and radiotherapy are standard treatment modalities for grade T1/T2 oral cavity cancer, both approaches have well-documented limitations, including their association with adverse effects that lower quality of life for patients.

Number of Metastatic Nodes a Predictor for Survival in Oral Cancer

October 24th 2017

The presence of metastatic lymph nodes was directly correlated with poorer survival in patients with oral cancer, according to findings published in the Journal of Clinical Oncology.

NICE Rejects Treatments for Bladder and Thyroid Cancer

October 21st 2017

The UK’s National Institute for Health and Care Excellence has issued guidelines recommending against nivolumab (Opdivo), lenvatinib (Lenvima), and sorafenib (Nexavar).

Dr. Gold on the Current State of HPV-Related Head and Neck Cancer

October 19th 2017

Kathryn A. Gold, MD, medical oncologist, associate professor of medicine, UC San Diego Heath, discusses the current state of human papilloma virus (HPV)-related head and neck cancer.

Dr. Zandberg on Biomarker Development in Head and Neck Cancer

October 18th 2017

Dan Zandberg, MD, assistant professor of medicine, the University of Maryland School of Medicine, discusses biomarker development in patients with head and neck cancer.

Dr. Zandberg on the Role of Immunotherapy in Head and Neck Cancer

October 18th 2017

Dan Zandberg, MD, assistant professor of medicine, University of Maryland School of Medicine, discusses the role of immunotherapy in head and neck cancer.

Dr. Zandberg on the Role of Durvalumab in Head and Neck Cancer

October 14th 2017

Dan Zandberg, MD, assistant professor of Medicine, the University of Maryland Medical Center, discusses the role of durvalumab (Imfinzi) in patients with metastatic head and neck cancer.

Novel Approach Reduces Treatment Toxicities in Patients With HPV-Related Oropharyngeal Cancer

October 5th 2017

The incidence of mouth and throat cancer is on the rise due to transmission of the human papilloma virus, but physicians at Memorial Sloan Kettering Cancer Center have managed to significantly reduce the intensity of treatment and improve quality of life for these patients.

Dr. Cohen Discusses the KEYNOTE-040 Trial in Head and Neck Cancer

September 22nd 2017

Ezra Cohen, MD, associate director, Moores Cancer Center at the University of California, San Diego, discusses the phase III KEYNOTE-040 trial in head and neck cancer.